EZH2 and mantle cell lymphoma: Mutations in the SET domain of the EZH2 gene that increased its tri-methylation activity are prevalent in other B cell lymphoma but have not been reported in the case of MCL, suggesting that high EZH2 expression in MCL is sufficient for augmenting oncogenic signaling [40, 138].